Skip to main content
TipRanks
Go Ultimate75% OFF

Ascendis Pharma (ASND1N) Stock Forecast & Price Target

0 Followers
See the Price Targets and Ratings of:

ASND1N Analyst Ratings

Strong Buy
20Ratings
19Buy1Hold0Sell
Based on 20 analysts giving stock ratings to Ascendis Pharma in the past 3 months

ASND1N Stock 12 Month Forecast

Mex$5,938▲(42.55% Upside)
Based on 20 Wall Street analysts offering 12 month price targets for Ascendis Pharma in the last 3 months. The average price target is MXN 5,938.13 with a high forecast of MXN 6,606.17 and a low forecast of MXN 5,084.53. The average price target represents a 42.55% change from the last price of MXN 4,165.55.
Highest Price TargetMex$6,606Average Price TargetMex$5,938Lowest Price TargetMex$5,085

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for MX:ASND1N
Price TargetArticle
BarclaysMex$6,105→Mex$6,328buy51.91%UpsideReiterated11/16/26
CitiMex$6,124→Mex$6,216buy49.24%UpsideReiterated11/16/26
TD CowenMex$6,328→Mex$6,532buy56.81%UpsideReiterated11/13/26
H.C. WainwrightMex$6,383→Mex$6,216buy49.24%UpsideReiterated11/13/26
Canaccord GenuityMex$4,973→Mex$5,085hold22.06%UpsideReiterated11/13/26
Wells FargoMex$6,049→Mex$6,124buy47.01%UpsideReiterated11/13/26
UBSMex$4,992→Mex$5,845buy40.33%UpsideAssigned11/13/26
WedbushMex$6,068→Mex$6,421buy54.14%UpsideReiterated11/13/26
Evercore ISIMex$6,049→Mex$6,606buy58.59%UpsideReiterated11/13/26
Morgan StanleyMex$5,066→Mex$5,604buy34.53%UpsideReiterated11/13/26
Leerink PartnersMex$6,049buy45.23%UpsideReiterated11/13/26
Bank of America SecuritiesMex$5,641buy35.43%UpsideReiterated11/12/26
RBC CapitalMex$5,381buy29.19%UpsideReiterated11/12/26
J.P. Morgan―buy―Reiterated10/10/26
Cantor FitzgeraldMex$5,567buy33.64%UpsideReiterated09/25/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PLSEPulse Biosciences
SLDBSolid Biosciences
RZLTRezolute
IMUXImmunic
MDWDMediwound

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Ascendis Pharma

3 Months
Alex Thompson CFA
Alex Thompson CFAStifel Nicolaus
Success Rate14/15 ratings generated profit
93%
Average Return
+7.71%

Copying Alex Thompson CFA's trades and holding each position for 3 Months would result in 93.33% of your transactions generating a profit, with an average return of +7.71% per trade.

1 Year
Alex Thompson CFA
Alex Thompson CFAStifel Nicolaus
Success Rate15/15 ratings generated profit
100%
Average Return
+35.70%

Copying Alex Thompson CFA's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +35.70% per trade.

2 Years
Paul Choi
Paul ChoiGoldman Sachs
Success Rate20/20 ratings generated profit
100%
Average Return
+68.86%

Copying Paul Choi's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +68.86% per trade.

ASND1N Analyst Recommendation Trends

020406080Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for ASND1N
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy00000
Buy2737475042
Hold00012
Sell00000
Strong Sell00000
total2737475144

In the current month, ASND1N has received 42 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. ASND1N average Analyst price target in the past 3 months is 5,938.13.

ASND1N Financial Forecast

Mex$-13Mex$40.3Mex$93.5Mex$146.8Mex$200Q1 2026Q3 2026Q4 2026
HighMex$46.22
ConsensusMex$33.13
LowMex$4.29

ASND1N Earnings Forecast

Next quarter’s earnings estimate for ASND1N is MXN 33.13 with a range of MXN 4.29 to MXN 46.22. The previous quarter’s EPS was MXN 22.09. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.

Mex$5.3BMex$6.2BMex$7.1BMex$8BMex$8.9BQ1 2026Q3 2026Q4 2026
HighMex$8.9B
ConsensusMex$8.45B
LowMex$7.73B

ASND1N Sales Forecast

Next quarter’s sales forecast for ASND1N is MXN 8.45B with a range of MXN 7.73B to MXN 8.90B. The previous quarter’s sales results were MXN 7.89B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

ASND1N Stock Forecast FAQ

What is MX:ASND1N’s average 12-month price target, according to analysts?
Based on analyst ratings, Ascendis Pharma’s 12-month average price target is Mex$5,938.13.
What is MX:ASND1N’s upside potential, based on the analysts’ average price target?
Ascendis Pharma has 42.55% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is Ascendis Pharma a Buy, Sell or Hold?
Ascendis Pharma has a consensus rating of Strong Buy, which is based on 19 buy ratings, 1 hold ratings and 0 sell ratings.
What is Ascendis Pharma’s share price target?
The average share price target for Ascendis Pharma is Mex$5,938.13. This is based on 20 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is Mex$6,606.17, and the lowest forecast is Mex$5,084.53. The average share price target represents a 42.55% increase from the current price of Mex$4,165.55.
What do analysts say about Ascendis Pharma?
Ascendis Pharma’s analyst rating consensus is a Strong Buy. This is based on the ratings of 20 Wall Street analysts.
How can I buy shares of Ascendis Pharma?
To buy shares of MX:ASND1N, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.